Filing Details
- Accession Number:
- 0001127602-20-021761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-17 17:34:20
- Reporting Period:
- 2020-07-15
- Accepted Time:
- 2020-07-17 17:34:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1682852 | Moderna Inc. | MRNA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1619929 | G Elizabeth Nabel | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-07-15 | 40,307 | $14.22 | 54,651 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-07-15 | 8,376 | $19.15 | 63,027 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-07-15 | 10,948 | $19.15 | 73,975 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-07-15 | 73,975 | $87.84 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-15 | 40,307 | $0.00 | 40,307 | $14.22 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-15 | 8,376 | $0.00 | 8,376 | $19.15 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-15 | 10,948 | $0.00 | 10,948 | $19.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2028-02-28 | No | 4 | M | Direct | |
0 | 2026-08-10 | No | 4 | M | Direct | |
0 | 2026-08-10 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2020.
- This option will become fully vested and exercisable on February 28, 2019.
- This option is fully vested and exercisable.